Poniard Pharmaceuticals Valuation

PARD Stock  USD 0.0001  0.00  0.00%   
Poniard Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Poniard Pharmaceuticals from analyzing the company fundamentals such as Price To Earning of (0.01) X, return on equity of -2.1, and Shares Outstanding of 1.5 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
0.0001
Please note that Poniard Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Poniard Pharmaceuticals is based on 3 months time horizon. Increasing Poniard Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Poniard pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Poniard Pharmaceuticals. Since Poniard Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Poniard Pink Sheet. However, Poniard Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.0E-4 Real  8.4E-5 Hype  1.0E-4 Naive  1.0E-4
The real value of Poniard Pink Sheet, also known as its intrinsic value, is the underlying worth of Poniard Pharmaceuticals Company, which is reflected in its stock price. It is based on Poniard Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Poniard Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.000084
Real Value
0.00
Upside
Estimating the potential upside or downside of Poniard Pharmaceuticals helps investors to forecast how Poniard pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Poniard Pharmaceuticals more accurately as focusing exclusively on Poniard Pharmaceuticals' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Naive
Forecast
LowNext ValueHigh
0.00010.00010.0001
Details

About Poniard Pharmaceuticals Valuation

The pink sheet valuation mechanism determines Poniard Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Poniard Pharmaceuticals. We calculate exposure to Poniard Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Poniard Pharmaceuticals's related companies.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Poniard Pharmaceuticals, Inc. was founded in 1984 and is based in Seattle, Washington. PONIARD PHARMACEUT operates under Biotechnology classification in the United States and is traded on PNK Exchange. It employs 7 people.

8 Steps to conduct Poniard Pharmaceuticals' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Poniard Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Poniard Pharmaceuticals' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Poniard Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Poniard Pharmaceuticals' revenue streams: Identify Poniard Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Poniard Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Poniard Pharmaceuticals' growth potential: Evaluate Poniard Pharmaceuticals' management, business model, and growth potential.
  • Determine Poniard Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Poniard Pharmaceuticals' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Poniard Pink Sheet analysis

When running Poniard Pharmaceuticals' price analysis, check to measure Poniard Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Poniard Pharmaceuticals is operating at the current time. Most of Poniard Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Poniard Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Poniard Pharmaceuticals' price. Additionally, you may evaluate how the addition of Poniard Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios